Deferred Tax Assets, Valuation Allowance of Citius Pharmaceuticals, Inc. from 30 Sep 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Citius Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2012 to 30 Sep 2025.
  • Citius Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2025 was $66,147,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Citius Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $66,147,000 +$12,321,000 +23% 30 Sep 2025 10-K 23 Dec 2025 2025 FY
Q3 2024 $53,826,000 +$8,911,000 +20% 30 Sep 2024 10-K 23 Dec 2025 2025 FY
Q3 2023 $44,915,000 +$34,161,000 +318% 30 Sep 2023 10-K 27 Dec 2024 2024 FY
Q3 2022 $10,754,000 -$1,503,000 -12% 30 Sep 2022 10-K 29 Dec 2023 2023 FY
Q3 2021 $12,257,000 +$8,666,000 +241% 30 Sep 2021 10-K 22 Dec 2022 2022 FY
Q3 2020 $3,591,000 -$9,738,000 -73% 30 Sep 2020 10-K 15 Dec 2021 2021 FY
Q3 2019 $13,329,000 +$3,017,000 +29% 30 Sep 2019 10-K 16 Dec 2020 2020 FY
Q3 2018 $10,312,000 +$1,764,000 +21% 30 Sep 2018 10-K 16 Dec 2019 2019 FY
Q3 2017 $8,548,000 +$4,044,000 +90% 30 Sep 2017 10-K 11 Dec 2018 2018 FY
Q3 2016 $4,504,000 +$6,019,000 30 Sep 2016 10-K 13 Dec 2017 2017 FY
Q3 2015 $1,515,000 -$1,299,000 -601% 30 Sep 2015 10-K 23 Dec 2016 2016 FY
Q3 2014 $216,000 -$311,216 -327% 30 Sep 2014 10-K 14 Dec 2015 2015 FY
Q3 2013 $95,216 +$31,369 +49% 30 Sep 2013 10-K 06 Feb 2014 2013 FY
Q3 2012 $63,847 30 Sep 2012 10-K 06 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.